SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042732
Filing Date
2021-08-09
Accepted
2021-08-09 17:17:30
Documents
97
Period of Report
2021-07-04

Document Format Files

Seq Description Document Type Size
1 10-Q ocdx-10q_20210704.htm   iXBRL 10-Q 3687110
2 EX-31.1 ocdx-ex311_9.htm EX-31.1 22599
3 EX-31.2 ocdx-ex312_7.htm EX-31.2 23046
4 EX-32.1 ocdx-ex321_6.htm EX-32.1 8125
5 EX-32.2 ocdx-ex322_8.htm EX-32.2 8145
  Complete submission text file 0001564590-21-042732.txt   13621137

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ocdx-20210704.xsd EX-101.SCH 79288
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocdx-20210704_cal.xml EX-101.CAL 63413
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocdx-20210704_def.xml EX-101.DEF 333932
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocdx-20210704_lab.xml EX-101.LAB 506957
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocdx-20210704_pre.xml EX-101.PRE 513845
11 EXTRACTED XBRL INSTANCE DOCUMENT ocdx-10q_20210704_htm.xml XML 3060368
Mailing Address 1001 ROUTE 202 RARITAN NJ 08869
Business Address 1001 ROUTE 202 RARITAN NJ 08869 (908) 218-8000
Ortho Clinical Diagnostics Holdings plc (Filer) CIK: 0001828443 (see all company filings)

IRS No.: 981151819 | State of Incorp.: X0 | Fiscal Year End: 0102
Type: 10-Q | Act: 34 | File No.: 001-39956 | Film No.: 211157471
SIC: 2835 In Vitro & In Vivo Diagnostic Substances